Adam F Saying ACAD To Be A Blockbuster. Anyone See This? Nice. read.
Thought Some Would Like to See Adam F Thoughts on ACAD:
The Street 6/11 By: Adam F
Baker Brothers, already the largest Acadia shareholder, disclosed an upsized 23 percent stake in the company last week. High-conviction stocks in the Baker Brothers portfolio -- think Seattle Genetics (SGEN_) and Pharmacyclics (PCYC_) -- tend to perform really well, sometimes regardless of near-term fundamentals.Oh yeah, it's worth noting that Acadia has a potential blockbuster drug in pimavanserin, which will be submitted to FDA as a new treatment for Parkinson's disease psychosis.